Skip to main content

Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal

Novavax, Inc announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, subject to success of pending clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.